"At St. Luke’s Regional Cancer Center, we have hand-selected cancer experts from some of the most prestigious oncology programs in the nation. While these physicians came here with a diverse mix of training and experience, they all share the same commitment and passion for treating your cancer with all of their minds—and all of their hearts. Together, St. Luke's Regional Cancer Center physicians, pharmacists and the excellent staff work together as one, aligned for the purpose of diagnosing and treating your cancer in the most effective way possible. We provide patients and families support for dealing with cancer. St. Luke’s also offers an extensive network of additional services for every step on the journey."

During the past decade, St. Luke's Hospital Cancer Care Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 16 clinical trials were completed, i.e. on average, 800% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Luke's Hospital Cancer Care Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 8 trials, followed by "NSABP Foundation Inc" with 6 trials sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored and "Eastern Cooperative Oncology Group" with 4 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Hospital Cancer Care Center" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Hospital Cancer Care Center" are "Breast Cancer" (10 trials), "Colorectal Cancer" (3 trials), "Prostate Cancer" (3 trials), "Acute Leukemia" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "St. Luke's Hospital Cancer Care Center" in a lesser frequency.

Most popular intervention types in "St. Luke's Hospital Cancer Care Center" are "Drug" (18 trials), "Radiation" (7 trials), "Other" (6 trials), "Biological" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (3 trials), "cyclophosphamide" (3 trials), "Carboplatin" (2 trials), "LHRH agonist" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Hospital Cancer Care Center" are 16 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "St. Luke's Hospital Cancer Care Center". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in St. Luke's Hospital Cancer Care Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Hospital Cancer Care Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".